These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

656 related articles for article (PubMed ID: 15897309)

  • 1. Increased pentosidine, an advanced glycation end product, in serum and synovial fluid from patients with knee osteoarthritis and its relation with cartilage oligomeric matrix protein.
    Senolt L; Braun M; Olejárová M; Forejtová S; Gatterová J; Pavelka K
    Ann Rheum Dis; 2005 Jun; 64(6):886-90. PubMed ID: 15897309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronic acid levels may have predictive value for the progression of knee osteoarthritis.
    Pavelka K; Forejtová S; Olejárová M; Gatterová J; Senolt L; Spacek P; Braun M; Hulejová M; Stovícková J; Pavelková A
    Osteoarthritis Cartilage; 2004 Apr; 12(4):277-83. PubMed ID: 15023379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end-product pentosidine is not a relevant marker of disease activity in patients with rheumatoid arthritis.
    Senolt L; Braun M; Vencovský J; Sedová L; Pavelka K
    Physiol Res; 2007; 56(6):771-777. PubMed ID: 17298211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cartilage oligomeric matrix protein (COMP): the role of a non-collagen cartilage matrix protein as a marker of disease activity and joint destruction in patients with rheumatoid arthritis and osteoarthritis].
    Marti C; Neidhart M; Gerber T; Hauser N; Michel BA; Häuselmann HJ
    Z Rheumatol; 1999 Apr; 58(2):79-87. PubMed ID: 10408068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK).
    Vos PA; DeGroot J; Huisman AM; Oostveen JC; Marijnissen AC; Bijlsma JW; van El B; Zuurmond AM; Lafeber FP
    Osteoarthritis Cartilage; 2010 Oct; 18(10):1329-36. PubMed ID: 20673850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
    Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cartilage oligomeric matrix protein (COMP) in rheumatoid arthritis and knee osteoarthritis.
    Wisłowska M; Jabłońska B
    Clin Rheumatol; 2005 Jun; 24(3):278-84. PubMed ID: 15940561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig.
    Huebner JL; Kraus VB
    Osteoarthritis Cartilage; 2006 Sep; 14(9):923-30. PubMed ID: 16679035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cartilage oligomeric matrix protein (COMP) levels in knee osteoarthritis in a Brazilian population: clinical and radiological correlation.
    Fernandes FA; Pucinelli ML; da Silva NP; Feldman D
    Scand J Rheumatol; 2007; 36(3):211-5. PubMed ID: 17657676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related decrease in susceptibility of human articular cartilage to matrix metalloproteinase-mediated degradation: the role of advanced glycation end products.
    DeGroot J; Verzijl N; Wenting-Van Wijk MJ; Bank RA; Lafeber FP; Bijlsma JW; TeKoppele JM
    Arthritis Rheum; 2001 Nov; 44(11):2562-71. PubMed ID: 11710713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis Project.
    Clark AG; Jordan JM; Vilim V; Renner JB; Dragomir AD; Luta G; Kraus VB
    Arthritis Rheum; 1999 Nov; 42(11):2356-64. PubMed ID: 10555031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cartilage oligomeric matrix protein in serum in systemic lupus erythematosus and knee osteoarthritis. Preliminary communication.
    Wisłowska M; Jabłońska B
    Rheumatol Int; 2005 Jun; 25(5):373-8. PubMed ID: 15739097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatan sulfate in the synovial fluid of patients with knee osteoarthritis.
    Momohara S; Okada N; Ikari K; Mizuno S; Okamoto H
    Mod Rheumatol; 2007; 17(4):301-5. PubMed ID: 17694263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation.
    Addison S; Coleman RE; Feng S; McDaniel G; Kraus VB
    Arthritis Rheum; 2009 Nov; 60(11):3366-73. PubMed ID: 19877068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pentosidine in synovial fluid in osteoarthritis and rheumatoid arthritis: relationship with disease activity in rheumatoid arthritis.
    Chen JR; Takahashi M; Suzuki M; Kushida K; Miyamoto S; Inoue T
    J Rheumatol; 1998 Dec; 25(12):2440-4. PubMed ID: 9858442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum cartilage oligomeric matrix protein reflects the presence of clinically diagnosed synovitis in patients with knee osteoarthritis.
    Vilím V; Vytásek R; Olejárová M; Machácek S; Gatterová J; Procházka B; Kraus VB; Pavelka K
    Osteoarthritis Cartilage; 2001 Oct; 9(7):612-8. PubMed ID: 11597173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts.
    Dodge GR; Hawkins D; Boesler E; Sakai L; Jimenez SA
    Osteoarthritis Cartilage; 1998 Nov; 6(6):435-40. PubMed ID: 10343777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker.
    Verma P; Dalal K
    J Orthop Res; 2013 Jul; 31(7):999-1006. PubMed ID: 23423905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients.
    Jung YO; Do JH; Kang HJ; Yoo SA; Yoon CH; Kim HA; Cho CS; Kim WU
    Clin Exp Rheumatol; 2006; 24(3):253-9. PubMed ID: 16870091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential and limitations of cartilage-specific (V+C)(-) fibronectin and cartilage oligomeric matrix protein as osteoarthritis biomarkers in canine synovial fluid.
    Steffey MA; Miura N; Todhunter RJ; Nykamp SG; Freeman KP; Scarpino V; Vernier-Singer MA; Erb HN; MacLeod JN; Lust G; Burton-Wurster N
    Osteoarthritis Cartilage; 2004 Oct; 12(10):818-25. PubMed ID: 15450532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.